Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

NMR vs GS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NMR
Nomura Holdings, Inc.

Financial - Capital Markets

Financial ServicesNYSE • JP
Market Cap$23.56B
5Y Perf.+91.5%
GS
The Goldman Sachs Group, Inc.

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$291.19B
5Y Perf.+377.0%

NMR vs GS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NMR logoNMR
GS logoGS
IndustryFinancial - Capital MarketsFinancial - Capital Markets
Market Cap$23.56B$291.19B
Revenue (TTM)$4.76T$126.85B
Net Income (TTM)$370.05B$16.67B
Gross Margin45.6%41.1%
Operating Margin11.3%14.5%
Forward P/E10.0x15.8x
Total Debt$17.30T$616.93B
Cash & Equiv.$4.30T$182.09B

NMR vs GSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NMR
GS
StockMay 20May 26Return
Nomura Holdings, In… (NMR)100191.5+91.5%
The Goldman Sachs G… (GS)100477.0+377.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: NMR vs GS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: GS leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Nomura Holdings, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
NMR
Nomura Holdings, Inc.
The Banking Pick

NMR is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 3 yrs, beta 1.32, yield 4.6%
  • Lower volatility, beta 1.32, current ratio 1.43x
  • PEG 0.51 vs GS's 1.13
Best for: income & stability and sleep-well-at-night
GS
The Goldman Sachs Group, Inc.
The Banking Pick

GS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 17.0%, EPS growth 77.3%
  • 5.4% 10Y total return vs NMR's 146.3%
  • 17.0% NII/revenue growth vs NMR's 5.6%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthGS logoGS17.0% NII/revenue growth vs NMR's 5.6%
ValueNMR logoNMRLower P/E (10.0x vs 15.8x), PEG 0.51 vs 1.13
Quality / MarginsGS logoGSEfficiency ratio 0.3% vs NMR's 0.3% (lower = leaner)
Stability / SafetyNMR logoNMRBeta 1.32 vs GS's 1.47, lower leverage
DividendsNMR logoNMR4.6% yield, 3-year raise streak, vs GS's 1.4%
Momentum (1Y)GS logoGS+73.4% vs NMR's +51.0%
Efficiency (ROA)GS logoGSEfficiency ratio 0.3% vs NMR's 0.3%

NMR vs GS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NMRNomura Holdings, Inc.
FY 2025
Brokerage Commissions
77.6%$264.5B
Other Commissions
22.4%$76.4B
GSThe Goldman Sachs Group, Inc.
FY 2024
Global Markets
65.3%$34.9B
Investment Management
30.2%$16.1B
Platform Solutions
4.5%$2.4B

NMR vs GS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLGSLAGGINGNMR

Income & Cash Flow (Last 12 Months)

GS leads this category, winning 4 of 5 comparable metrics.

NMR is the larger business by revenue, generating $4.76T annually — 37.5x GS's $126.9B. Profitability is closely matched — net margins range from 11.3% (GS) to 7.6% (NMR).

MetricNMR logoNMRNomura Holdings, …GS logoGSThe Goldman Sachs…
RevenueTrailing 12 months$4.76T$126.9B
EBITDAEarnings before interest/tax$533.0B$23.4B
Net IncomeAfter-tax profit$370.1B$16.7B
Free Cash FlowCash after capex$0$15.8B
Gross MarginGross profit ÷ Revenue+45.6%+41.1%
Operating MarginEBIT ÷ Revenue+11.3%+14.5%
Net MarginNet income ÷ Revenue+7.6%+11.3%
FCF MarginFCF ÷ Revenue-25.2%-12.1%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year-5.5%+45.8%
GS leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

NMR leads this category, winning 6 of 6 comparable metrics.

At 10.7x trailing earnings, NMR trades at a 54% valuation discount to GS's 23.1x P/E. Adjusting for growth (PEG ratio), NMR offers better value at 0.55x vs GS's 1.65x — a lower PEG means you pay less per unit of expected earnings growth.

MetricNMR logoNMRNomura Holdings, …GS logoGSThe Goldman Sachs…
Market CapShares × price$23.6B$291.2B
Enterprise ValueMkt cap + debt − cash$106.8B$726.0B
Trailing P/EPrice ÷ TTM EPS10.71x23.12x
Forward P/EPrice ÷ next-FY EPS est.9.99x15.84x
PEG RatioP/E ÷ EPS growth rate0.55x1.65x
EV / EBITDAEnterprise value multiple27.43x34.92x
Price / SalesMarket cap ÷ Revenue0.77x2.30x
Price / BookPrice ÷ Book value/share1.01x2.56x
Price / FCFMarket cap ÷ FCF
NMR leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

GS leads this category, winning 7 of 9 comparable metrics.

GS delivers a 12.6% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $10 for NMR. NMR carries lower financial leverage with a 4.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 5.06x. On the Piotroski fundamental quality scale (0–9), NMR scores 5/9 vs GS's 4/9, reflecting solid financial health.

MetricNMR logoNMRNomura Holdings, …GS logoGSThe Goldman Sachs…
ROE (TTM)Return on equity+10.2%+12.6%
ROA (TTM)Return on assets+0.6%+0.9%
ROICReturn on invested capital+1.4%+1.9%
ROCEReturn on capital employed+2.4%+3.6%
Piotroski ScoreFundamental quality 0–954
Debt / EquityFinancial leverage4.49x5.06x
Net DebtTotal debt minus cash$13.00T$434.8B
Cash & Equiv.Liquid assets$4.30T$182.1B
Total DebtShort + long-term debt$17.30T$616.9B
Interest CoverageEBIT ÷ Interest expense0.20x0.31x
GS leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

GS leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in GS five years ago would be worth $27,109 today (with dividends reinvested), compared to $16,867 for NMR. Over the past 12 months, GS leads with a +73.4% total return vs NMR's +51.0%. The 3-year compound annual growth rate (CAGR) favors GS at 44.0% vs NMR's 36.1% — a key indicator of consistent wealth creation.

MetricNMR logoNMRNomura Holdings, …GS logoGSThe Goldman Sachs…
YTD ReturnYear-to-date-3.4%+3.0%
1-Year ReturnPast 12 months+51.0%+73.4%
3-Year ReturnCumulative with dividends+152.1%+198.7%
5-Year ReturnCumulative with dividends+68.7%+171.1%
10-Year ReturnCumulative with dividends+146.3%+536.1%
CAGR (3Y)Annualised 3-year return+36.1%+44.0%
GS leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — NMR and GS each lead in 1 of 2 comparable metrics.

NMR is the less volatile stock with a 1.32 beta — it tends to amplify market swings less than GS's 1.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GS currently trades 95.2% from its 52-week high vs NMR's 85.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNMR logoNMRNomura Holdings, …GS logoGSThe Goldman Sachs…
Beta (5Y)Sensitivity to S&P 5001.32x1.47x
52-Week HighHighest price in past year$9.58$984.70
52-Week LowLowest price in past year$5.48$547.06
% of 52W HighCurrent price vs 52-week peak+85.2%+95.2%
RSI (14)Momentum oscillator 0–10044.455.0
Avg Volume (50D)Average daily shares traded2.1M2.0M
Evenly matched — NMR and GS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — NMR and GS each lead in 1 of 2 comparable metrics.

Wall Street rates NMR as "Hold" and GS as "Hold". Consensus price targets imply 6.2% upside for GS (target: $996) vs -29.0% for NMR (target: $6). For income investors, NMR offers the higher dividend yield at 4.63% vs GS's 1.44%.

MetricNMR logoNMRNomura Holdings, …GS logoGSThe Goldman Sachs…
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$5.79$995.89
# AnalystsCovering analysts955
Dividend YieldAnnual dividend ÷ price+4.6%+1.4%
Dividend StreakConsecutive years of raises312
Dividend / ShareAnnual DPS$59.06$13.48
Buyback YieldShare repurchases ÷ mkt cap+2.8%+3.5%
Evenly matched — NMR and GS each lead in 1 of 2 comparable metrics.
Key Takeaway

GS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NMR leads in 1 (Valuation Metrics). 2 tied.

Best OverallThe Goldman Sachs Group, In… (GS)Leads 3 of 6 categories
Loading custom metrics...

NMR vs GS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is NMR or GS a better buy right now?

For growth investors, The Goldman Sachs Group, Inc.

(GS) is the stronger pick with 17. 0% revenue growth year-over-year, versus 5. 6% for Nomura Holdings, Inc. (NMR). Nomura Holdings, Inc. (NMR) offers the better valuation at 10. 7x trailing P/E (10. 0x forward), making it the more compelling value choice. Analysts rate Nomura Holdings, Inc. (NMR) a "Hold" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NMR or GS?

On trailing P/E, Nomura Holdings, Inc.

(NMR) is the cheapest at 10. 7x versus The Goldman Sachs Group, Inc. at 23. 1x. On forward P/E, Nomura Holdings, Inc. is actually cheaper at 10. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Nomura Holdings, Inc. wins at 0. 51x versus The Goldman Sachs Group, Inc. 's 1. 13x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — NMR or GS?

Over the past 5 years, The Goldman Sachs Group, Inc.

(GS) delivered a total return of +171. 1%, compared to +68. 7% for Nomura Holdings, Inc. (NMR). Over 10 years, the gap is even starker: GS returned +536. 1% versus NMR's +146. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NMR or GS?

By beta (market sensitivity over 5 years), Nomura Holdings, Inc.

(NMR) is the lower-risk stock at 1. 32β versus The Goldman Sachs Group, Inc. 's 1. 47β — meaning GS is approximately 11% more volatile than NMR relative to the S&P 500. On balance sheet safety, Nomura Holdings, Inc. (NMR) carries a lower debt/equity ratio of 4% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — NMR or GS?

By revenue growth (latest reported year), The Goldman Sachs Group, Inc.

(GS) is pulling ahead at 17. 0% versus 5. 6% for Nomura Holdings, Inc. (NMR). On earnings-per-share growth, the picture is similar: The Goldman Sachs Group, Inc. grew EPS 77. 3% year-over-year, compared to 7. 2% for Nomura Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — NMR or GS?

The Goldman Sachs Group, Inc.

(GS) is the more profitable company, earning 11. 3% net margin versus 7. 6% for Nomura Holdings, Inc. — meaning it keeps 11. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GS leads at 14. 5% versus 11. 3% for NMR. At the gross margin level — before operating expenses — NMR leads at 45. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is NMR or GS more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Nomura Holdings, Inc. (NMR) is the more undervalued stock at a PEG of 0. 51x versus The Goldman Sachs Group, Inc. 's 1. 13x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Nomura Holdings, Inc. (NMR) trades at 10. 0x forward P/E versus 15. 8x for The Goldman Sachs Group, Inc. — 5. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GS: 6. 2% to $995. 89.

08

Which pays a better dividend — NMR or GS?

All stocks in this comparison pay dividends.

Nomura Holdings, Inc. (NMR) offers the highest yield at 4. 6%, versus 1. 4% for The Goldman Sachs Group, Inc. (GS).

09

Is NMR or GS better for a retirement portfolio?

For long-horizon retirement investors, The Goldman Sachs Group, Inc.

(GS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 4% yield, +536. 1% 10Y return). Both have compounded well over 10 years (GS: +536. 1%, NMR: +146. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between NMR and GS?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NMR is a mid-cap deep-value stock; GS is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

NMR

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

GS

High-Growth Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform NMR and GS on the metrics below

Revenue Growth>
%
(NMR: 5.6% · GS: 17.0%)
Net Margin>
%
(NMR: 7.6% · GS: 11.3%)
P/E Ratio<
x
(NMR: 10.7x · GS: 23.1x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.